Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Livagen

Lys-Glu-Asp-Ala, Tetrapeptide KEDA

Quick Stats
Studies 10
Trials 22
Score 1
2002 pubmed

[Functional morphology of an organotypic liver culture exposed to the peptide livagen].

Riadnova. I Iu IIu; Filippov. S V SV; Iuzhakov. V V VV

Key Findings

  • Livagen stimulates structural and functional homeostasis in organotypic liver cultures.
  • The peptide stabilizes morphological safety of liver cell populations.
  • Livagen reinforces cellular and intracellular regeneration processes in the liver culture.

Practical Outcomes

  • Livagen shows promising effects on liver cell health in a laboratory setting, but there is no information on how to use it in humans, appropriate dosages, or safety. For biohackers, the study is not yet actionable; further animal and clinical research would be needed before any real-world protocols could be developed.

Summary

The researchers tested a tiny protein called livagen on liver cells grown in a lab dish and found it helped keep the cells stable and supported their ability to regenerate, but the work was only done in vitro and no human data or dosing guidance were provided.

Abstract

In this study the results of the tetrapeptide livagen effect on functional morphological characteristics have been produced. Under the data of the immunocytochemical and morphometrical analysis, tetrapeptide stimulates structural and functional homeostasis of cell populations in the liver culture. It was demonstrated that the main activity of investigated peptide had been directed to the stabilisation of morphological safety and reinforcement of the processes of cellular and intracellular forms of regeneration.

Study Information

Provider

pubmed

Year

2002